Jeffrey Freitag, M.D., senior vice president, PharmaNet Consulting, will also become chief medical officer of PharmaNet Development Group, Inc. Dr. Freitag will be the senior medical representative for the company and provide guidance to physicians involved in designing and monitoring Phase I – Phase III trials. He will also continue to head PharmaNet’s team of regulatory and pharmaceutical consultants. “Excellence in pharmaceutical science and medicine is critical to the su...